BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 18989900)

  • 1. Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and Jamaica.
    Birmann BM; Breen EC; Stuver S; Cranston B; Martínez-Maza O; Falk KI; Okayama A; Hanchard B; Mueller N; Hisada M
    Int J Cancer; 2009 Feb; 124(3):614-21. PubMed ID: 18989900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers.
    Hisada M; Stuver SO; Okayama A; Li HC; Sawada T; Hanchard B; Mueller NE
    J Infect Dis; 2004 Nov; 190(9):1605-9. PubMed ID: 15478065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.
    Enose-Akahata Y; Abrams A; Johnson KR; Maloney EM; Jacobson S
    Blood; 2012 Mar; 119(12):2829-36. PubMed ID: 22318200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals.
    Enose-Akahata Y; Abrams A; Massoud R; Bialuk I; Johnson KR; Green PL; Maloney EM; Jacobson S
    Retrovirology; 2013 Feb; 10():19. PubMed ID: 23405908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
    Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA types.
    Goedert JJ; Li HC; Gao XJ; Chatterjee N; Sonoda S; Biggar RJ; Cranston B; Kim N; Carrington M; Morgan O; Hanchard B; Hisada M
    Int J Cancer; 2007 Sep; 121(5):1092-7. PubMed ID: 17437273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate of positive autoimmune markers in Human T lymphotropic virus type 1 carriers: a case-control study from Iran.
    Ahmadi Ghezeldasht S; Hedayati-Moghaddam MR; Habibi M; Mollahosseini F; Rafatpanah H; Miri R; Hatef Fard M; Sahebari M
    Int J Rheum Dis; 2018 Jan; 21(1):108-113. PubMed ID: 28261958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of humoral and cellular immune markers in human T-cell lymphotropic virus type 1 (HTLV-1) asymptomatic carriers in northeastern Iran, Mashhad.
    Hedayati-Moghaddam MR; Mollahosseini F; Namazi MJ; Mosavat A; Rezaee SA; Mahdifar M; Bidkhori HR; Valizadeh N; Rafatpanah H
    J Neurovirol; 2020 Dec; 26(6):863-869. PubMed ID: 33025348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral-specific humoral immune responses following transfusion-related transmission of human T cell lymphotropic virus type-I infection.
    Manns A; Wilks RJ; Hanchard B; Morgan OS; Rudolph DL; Lal RB
    Viral Immunol; 1994; 7(3):113-20. PubMed ID: 7598784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematologic and biochemical changes associated with human T lymphotropic virus type 1 infection in Jamaica: a report from the population-based blood donors study.
    Chaturvedi AK; Wilson M; Sanders-Lewis KA; Katki HA; Urquhart N; Walters MA; Miley W; Cranston B; Hanchard B; Hisada M
    Clin Infect Dis; 2007 Oct; 45(8):975-82. PubMed ID: 17879911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to HTLV-I(ACH) during acute infection of pig-tailed macaques.
    McGinn TM; Wei Q; Stallworth J; Fultz PN
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):443-56. PubMed ID: 15157363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
    de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
    J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Line Immunoassay to Detect HTLV-1 Infection in an Endemic Area, Southwestern Japan; Comparison with Polymerase Chain Reaction and Western Blot.
    Umeki K; Umekita K; Hashikura Y; Yamamoto I; Kubo K; Nagatomo Y; Okayama A
    Clin Lab; 2017 Feb; 63(2):227-233. PubMed ID: 28182361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of serum type 1 and type 2 immune markers in healthy carriers of HTLV-I.
    Birmann BM; Mueller NE; Okayama A; Hsieh CC; Tsubouchi H; Harn D; Stuver SO
    J Med Virol; 2006 Jun; 78(6):847-52. PubMed ID: 16628590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
    Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high prevalence of human T-lymphotropic virus type I carriers in patients with antithyroid antibodies.
    Mizokami T; Okamura K; Ikenoue H; Sato K; Kuroda T; Maeda Y; Fujishima M
    Thyroid; 1994; 4(4):415-9. PubMed ID: 7711504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroincidence of human T-lymphotropic virus type I infection and characterization of seroconverters in Jamaican food handlers.
    VanVeldhuisen PC; Walters M; Sawada T; Levine PH; Wilks R; Hanchard B; Hisada M
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):387-92. PubMed ID: 12843751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I.
    Hisada M; Okayama A; Shioiri S; Spiegelman DL; Stuver SO; Mueller NE
    Blood; 1998 Nov; 92(10):3557-61. PubMed ID: 9808547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.